Recombinant adiponectin failed to induce sufficient apoptosis in MDA‐MB‐157 triple negative breast cancer cells (Figure 2a–d), possibly due to the downregulation of T‐cadherin, a receptor of HMW adiponectin, as previously reported.4, 6, 7. Here, ADIPOQ is linked to triple-negative breast carcinoma.